These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 29029794)

  • 1. Rho-kinase inhibition reverses impaired Ca
    Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
    Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.
    Yang Y; Rong X; Lv X; Jiang W; Yang Y; Lai D; Xu S; Fu G
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28665545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early testosterone replacement attenuates intracellular calcium dyshomeostasis in the heart of testosterone-deprived male rats.
    Weerateerangkul P; Shinlapawittayatorn K; Palee S; Apaijai N; Chattipakorn SC; Chattipakorn N
    Cell Calcium; 2017 Nov; 67():22-30. PubMed ID: 29029787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ellagic Acid Prevents Ca
    Yamasan BE; Mercan T; Erkan O; Ozdemir S
    Cardiovasc Toxicol; 2021 Aug; 21(8):630-641. PubMed ID: 33909254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orai1 Channel Inhibition Preserves Left Ventricular Systolic Function and Normal Ca
    Bartoli F; Bailey MA; Rode B; Mateo P; Antigny F; Bedouet K; Gerbaud P; Gosain R; Plante J; Norman K; Gomez S; Lefebvre F; Rucker-Martin C; Ainscough JFX; Kearney MT; Bruns AF; Shi J; Appleby HL; Young RS; Shawer HM; Debant M; Gomez AM; Beech DJ; Foster R; Benitah JP; Sabourin J
    Circulation; 2020 Jan; 141(3):199-216. PubMed ID: 31906693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression of Rho/Rho kinase of cardiac muscle in heart failure rats caused by pressure overload and the intervention of fasudil].
    Zhang M; Qu C; Zeng DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):73-6. PubMed ID: 15924788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shen'ge powder decreases the cardiomyocyte hypertrophy in chronic heart failure by activating the Rho protein/Rho-associated coiledcoil forming protein kinase signaling pathway.
    Yan X; Jiao K; Song X
    J Cell Biochem; 2019 Mar; 120(3):3038-3045. PubMed ID: 30474257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early calcium handling imbalance in pressure overload-induced heart failure with nearly normal left ventricular ejection fraction.
    Rouhana S; Farah C; Roy J; Finan A; Rodrigues de Araujo G; Bideaux P; Scheuermann V; Saliba Y; Reboul C; Cazorla O; Aimond F; Richard S; Thireau J; Fares N
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):230-242. PubMed ID: 30463691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca(2+) leak through TLR4-ROS signaling in cardiomyocytes.
    Zhang C; Mo M; Ding W; Liu W; Yan D; Deng J; Luo X; Liu J
    J Mol Cell Cardiol; 2014 Sep; 74():260-73. PubMed ID: 24937603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
    Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
    J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
    Li Q; Xu Y; Li X; Guo Y; Liu G
    Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure.
    Wang LC; Ma H; He JG; Liao XX; Chen WF; Leng XY; Ma L; Mai WY; Tao J; Zeng WT; Liu J; Dong YG; Tang AL; Feng C
    Chin Med J (Engl); 2005 May; 118(9):731-7. PubMed ID: 15899134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca
    Baier MJ; Klatt S; Hammer KP; Maier LS; Rokita AG
    J Mol Cell Cardiol; 2020 Jan; 138():212-221. PubMed ID: 31836540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose combination of Rho kinase and L-type Ca(2+) channel antagonists for selective inhibition of depolarization-induced sustained arterial contraction.
    Porras-González C; González-Rodríguez P; Calderón-Sánchez E; López-Barneo J; Ureña J
    Eur J Pharmacol; 2014 Jun; 732():130-8. PubMed ID: 24680953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaMKIIδC Drives Early Adaptive Ca
    Ljubojevic-Holzer S; Herren AW; Djalinac N; Voglhuber J; Morotti S; Holzer M; Wood BM; Abdellatif M; Matzer I; Sacherer M; Radulovic S; Wallner M; Ivanov M; Wagner S; Sossalla S; von Lewinski D; Pieske B; Brown JH; Sedej S; Bossuyt J; Bers DM
    Circ Res; 2020 Oct; 127(9):1159-1178. PubMed ID: 32821022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload.
    Schwarz B; Percy E; Gao XM; Dart AM; Richardt G; Du XJ
    Eur J Heart Fail; 2003 Mar; 5(2):131-6. PubMed ID: 12644002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale reorganization of sarcoplasmic reticulum in pressure-overload cardiac hypertrophy visualized by dSTORM.
    Hadipour-Lakmehsari S; Driouchi A; Lee SH; Kuzmanov U; Callaghan NI; Heximer SP; Simmons CA; Yip CM; Gramolini AO
    Sci Rep; 2019 May; 9(1):7867. PubMed ID: 31133706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine activates calcium/calmodulin kinase II and causes cardiomyocyte hypertrophy.
    Henning RJ; Cuevas J
    J Cardiovasc Pharmacol; 2006 Jul; 48(1):802-13. PubMed ID: 16891908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
    Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
    Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.